Development of super Vδ2 T cells for relapsed/refractory acute myeloid Leukemia via non-viral site-specific integration
- DOI
- 10.1016/j.intimp.2026.116981
- Published
- 2026-09
- Container
- International Immunopharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2026.116981,
title = {Development of super Vδ2 T cells for relapsed/refractory acute myeloid Leukemia via non-viral site-specific integration},
author = {Li Liu and Hanlu Wang and Lin Shi and Chao Zhang and Leshuai Zhang and Lulu Lv and Yongzeng Wang},
year = {2026},
journal = {International Immunopharmacology},
doi = {10.1016/j.intimp.2026.116981},
url = {https://doi.org/10.1016/j.intimp.2026.116981}
}RIS
TY - JOUR TI - Development of super Vδ2 T cells for relapsed/refractory acute myeloid Leukemia via non-viral site-specific integration AU - Li Liu AU - Hanlu Wang AU - Lin Shi AU - Chao Zhang AU - Leshuai Zhang AU - Lulu Lv AU - Yongzeng Wang PY - 2026 JO - International Immunopharmacology DO - 10.1016/j.intimp.2026.116981 UR - https://doi.org/10.1016/j.intimp.2026.116981 ER -
APA
Liu, L., Wang, H., Shi, L., Zhang, C., Zhang, L., Lv, L., & Wang, Y. (2026). Development of super Vδ2 T cells for relapsed/refractory acute myeloid Leukemia via non-viral site-specific integration. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116981
Source records
- crossref · retrieved 2026-09-26T13:52:41.832Z